These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 32837681)

  • 41. From electrochemistry to enzyme kinetics of cytochrome P450.
    Shumyantseva VV; Kuzikov AV; Masamrekh RA; Bulko TV; Archakov AI
    Biosens Bioelectron; 2018 Dec; 121():192-204. PubMed ID: 30218927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters.
    Rendic S; Guengerich FP
    Curr Drug Metab; 2020; 21(14):1127-1135. PubMed ID: 33292107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of cytochrome P450 enzymes and biochemical aspects of mechanism-based inactivation (MBI).
    Kamel A; Harriman S
    Drug Discov Today Technol; 2013; 10(1):e177-89. PubMed ID: 24050247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Streptomyces cytochromes P450: applications in drug metabolism.
    Lamb DC; Waterman MR; Zhao B
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1279-94. PubMed ID: 23738914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes.
    Xing J; Kirby BJ; Whittington D; Wan Y; Goodlett DR
    Drug Metab Dispos; 2012 Sep; 40(9):1757-64. PubMed ID: 22679214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
    Ingelman-Sundberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):89-104. PubMed ID: 14574440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies as a probe in cytochrome P450 research.
    Shou M; Lu AY
    Drug Metab Dispos; 2009 May; 37(5):925-31. PubMed ID: 19196844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward Computational Understanding of Molecular Recognition in the Human Metabolizing Cytochrome P450s.
    Kontoyianni M; Lacy B
    Curr Med Chem; 2018; 25(28):3353-3373. PubMed ID: 29484977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of Cytochrome P450 in Metabolism of Ethanol and Carcinogens.
    Peter Guengerich F; Avadhani NG
    Adv Exp Med Biol; 2018; 1032():15-35. PubMed ID: 30362088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In silico prediction models of the induction of drug-metabolizing enzymes for drug discovery].
    Yoshinari K; Nagai M
    Nihon Yakurigaku Zasshi; 2019; 153(4):186-191. PubMed ID: 30971659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.
    Yang X; Zhang B; Molony C; Chudin E; Hao K; Zhu J; Gaedigk A; Suver C; Zhong H; Leeder JS; Guengerich FP; Strom SC; Schuetz E; Rushmore TH; Ulrich RG; Slatter JG; Schadt EE; Kasarskis A; Lum PY
    Genome Res; 2010 Aug; 20(8):1020-36. PubMed ID: 20538623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytochrome P450 enzymes: a review on drug metabolizing enzyme inhibition studies in drug discovery and development.
    Rao Gajula SN; Pillai MS; Samanthula G; Sonti R
    Bioanalysis; 2021 Sep; ():. PubMed ID: 34517735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole genome co-expression analysis of soybean cytochrome P450 genes identifies nodulation-specific P450 monooxygenases.
    Guttikonda SK; Trupti J; Bisht NC; Chen H; An YQ; Pandey S; Xu D; Yu O
    BMC Plant Biol; 2010 Nov; 10():243. PubMed ID: 21062474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-metabolizing enzymes: mechanisms and functions.
    Sheweita SA
    Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro cytochrome P450 inhibition and induction.
    Walsky RL; Boldt SE
    Curr Drug Metab; 2008 Nov; 9(9):928-39. PubMed ID: 18991590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of recombinant cytochrome p450 enzymes: a drug metabolism perspective.
    Tang W; Wang RW; Lu AY
    Curr Drug Metab; 2005 Oct; 6(5):503-17. PubMed ID: 16248842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism-Based Inactivation of Cytochrome P450 Enzymes: Computational Insights.
    Mirzaei MS; Ivanov MV; Taherpour AA; Mirzaei S
    Chem Res Toxicol; 2021 Apr; 34(4):959-987. PubMed ID: 33769041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
    Lynch T; Price A
    Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K; Khattar SK; Saini KS
    Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.